Mitochondrial fragmentation in neuronal degeneration: Toward an understanding of HD striatal susceptibility
- PMID: 27514446
- DOI: 10.1016/j.bbrc.2016.08.042
Mitochondrial fragmentation in neuronal degeneration: Toward an understanding of HD striatal susceptibility
Abstract
Huntington's disease (HD) is an autosomal-dominant progressive neurodegenerative disorder that primarily affects medium spiny neurons within the striatum. HD is caused by inheritance of an expanded CAG repeat in the HTT gene, resulting in a mutant huntingtin (mHtt) protein containing extra glutamine residues. Despite the advances in understanding the molecular mechanisms involved in HD the preferential vulnerability of the striatum remains an intriguing question. This review discusses current knowledge that links altered mitochondrial dynamics with striatal susceptibility in HD. We also highlight how the modulation of mitochondrial function may constitute an attractive therapeutic approach to reduce mHtt-induced toxicity and therefore prevent the selective striatal neurodegeneration.
Keywords: Huntingtin; Mitochondria fission; Striatal vulnerability.
Copyright © 2016. Published by Elsevier Inc.
Similar articles
-
Mitochondrial bioenergetics and dynamics in Huntington's disease: tripartite synapses and selective striatal degeneration.J Bioenerg Biomembr. 2010 Jun;42(3):227-34. doi: 10.1007/s10863-010-9287-6. J Bioenerg Biomembr. 2010. PMID: 20454921 Review.
-
Nature and cause of mitochondrial dysfunction in Huntington's disease: focusing on huntingtin and the striatum.J Neurochem. 2010 Jul;114(1):1-12. doi: 10.1111/j.1471-4159.2010.06741.x. Epub 2010 Apr 9. J Neurochem. 2010. PMID: 20403078 Review.
-
Neuronal targets for reducing mutant huntingtin expression to ameliorate disease in a mouse model of Huntington's disease.Nat Med. 2014 May;20(5):536-41. doi: 10.1038/nm.3514. Epub 2014 Apr 28. Nat Med. 2014. PMID: 24784230 Free PMC article.
-
Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease.Neurotherapeutics. 2012 Apr;9(2):270-84. doi: 10.1007/s13311-012-0112-2. Neurotherapeutics. 2012. PMID: 22441874 Free PMC article. Review.
-
Mitochondria in Huntington's disease.Biochim Biophys Acta. 2010 Jan;1802(1):52-61. doi: 10.1016/j.bbadis.2009.07.012. Epub 2009 Aug 11. Biochim Biophys Acta. 2010. PMID: 19682570 Review.
Cited by
-
Deterioration of mitochondrial bioenergetics and ultrastructure impairment in skeletal muscle of a transgenic minipig model in the early stages of Huntington's disease.Dis Model Mech. 2019 Jul 26;12(7):dmm038737. doi: 10.1242/dmm.038737. Dis Model Mech. 2019. PMID: 31278192 Free PMC article.
-
Mitochondria-Targeted Peptide SS31 Attenuates Renal Tubulointerstitial Injury via Inhibiting Mitochondrial Fission in Diabetic Mice.Oxid Med Cell Longev. 2019 Jun 2;2019:2346580. doi: 10.1155/2019/2346580. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 31281569 Free PMC article.
-
Differential response of neurons to autophagy modulation in Huntington's disease.Autophagy Rep. 2025 Jun 30;4(1):2519102. doi: 10.1080/27694127.2025.2519102. eCollection 2025. Autophagy Rep. 2025. PMID: 40607262 Free PMC article.
-
Mdivi-1 Alleviates Early Brain Injury After Experimental Subarachnoid Hemorrhage in Rats, Possibly via Inhibition of Drp1-Activated Mitochondrial Fission and Oxidative Stress.Neurochem Res. 2017 May;42(5):1449-1458. doi: 10.1007/s11064-017-2201-4. Epub 2017 Feb 16. Neurochem Res. 2017. PMID: 28210956
-
Targeting the proteostasis network in Huntington's disease.Ageing Res Rev. 2019 Jan;49:92-103. doi: 10.1016/j.arr.2018.11.006. Epub 2018 Nov 28. Ageing Res Rev. 2019. PMID: 30502498 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical